Page 48 - Read Online

Page 8 of 9 Jain et al. Rare Dis Orphan Drugs J 2024;3:8 https://dx.doi.org/10.20517/rdodj.2023.42

/pib.gov.in/PressReleasePage.aspx?PRID=1942712 [Last accessed on 28 Feb 2024].
17. Digital portal for crowdfunding & voluntary donations for patients of rare diseases. Available from: https://rarediseases.mohfw.gov.in/
Hospital_Treating_Rare_Diseases [Last accessed on 28 Feb 2024].
18. Ministry of Chemicals and Fertilizers. Dr Mansukh Mandaviya launches national policy on research and development and innovation
in pharma-MedTech sector in India and Scheme for promotion of research and innovation in pharma MedTech sector (PRIP).
Available from: https://pib.gov.in/PressReleasePage.aspx?PRID=1960812 [Last accessed on 28 Feb 2024].
19. First Chinese catalog of rare diseases. 2018. Available from: https://www.gov.cn/zhengce/zhengceku/2018-12/31/content_5435167.
htm [Last accessed on 28 Feb 2024].
20. Second Chinese catalog of rare diseases. 2023. Available from: https://www.gov.cn/zhengce/zhengceku/202309/content_6905273.htm
[Last accessed on 28 Feb 2024].
21. CHARD. 2023. Available from: https://www.chard.org.cn/detail/news/1941 [Last accessed on 28 Feb 2024].
22. Available from: https://www.gov.cn/zhengce/zhengceku/2019-10/08/content_5436962.htm [Last accessed on 28 Feb 2024].
23. Guo J, Liu P, Chen L, et al; Administrative group of national rare diseases registry system of China. National rare diseases registry
system (NRDRS): China’s first nation-wide rare diseases demographic analyses. Orphanet J Rare Dis 2021;16:515. DOI PubMed
PMC
24. Yayasan MPS & Penyakit Langka. Official opening of indonesia center of excellence for rare diseases. 2017. Available from: https://
www.penyakitlangkaindonesia.org/events/official-opening-indonesia-center-excellence-rare-diseases [Last accessed on 28 Feb 2024].
25. Act on medical care for patients with intractable diseases. 1993. Available from: https://www.japaneselawtranslation.go.jp/ja/laws/
view/3363 [Last accessed on 28 Feb 2024].
26. Act on securing quality, efficacy and safety of products including pharmaceuticals and medical devices. 1960. Available from: https://
www.japaneselawtranslation.go.jp/ja/laws/view/3213 [Last accessed on 28 Feb 2024].
27. Republic act No. 10747. An act promulgating a comprehensive policy in addressing the needs of persons with rare disease. 2016.
Available from: https://www.officialgazette.gov.ph/2016/03/03/republic-act-no-10747/ [Last accessed on 28 Feb 2024].
28. Manalansan A. Rare diseases: patients should not be left behind. BusinessWorld. 2022. Available from: https://www.
bworldonline.com/opinion/2022/02/01/427221/rare-diseases-patients-should-not-be-left-behind/ [Last accessed on 28 Feb 2024].
29. Republic act no. 9288. An act promulgating a comprehensive policy and a national system for ensuring newborn screening. 2004.
Available from: https://lawphil.net/statutes/repacts/ra2004/ra_9288_2004.html [Last accessed on 28 Feb 2024].
30. Law No. 105/2016/QH13. 2016. Available from: https://vss.gov.vn/english/legal/pages/default.aspx?ItemID=3550 [Last accessed on
28 Feb 2024].
31. Nature Portfolio. Fast-tracking rare disease diagnosis and treatment. Available from: https://www.nature.com/articles/d42473-020-
00209-6 [Last accessed on 28 Feb 2024].
32. Sciascia S, Roccatello D, Salvatore M, et al. Unmet needs in countries participating in the undiagnosed diseases network international:
an international survey considering national health care and economic indicators. Front Public Health 2023;11:1248260. DOI
PubMed PMC
33. Kim MJ, Kim B, Lee H, et al. The Korean genetic diagnosis program for rare disease phase II: outcomes of a 6-year national project.
Eur J Hum Genet 2023;31:1147-53. DOI PubMed PMC
34. Pharmaceutical affairs act. Available from: https://elaw.klri.re.kr/eng_mobile/viewer.do?hseq=57508&type=sogan&key=10 [Last
accessed on 28 Feb 2024].
35. Ministry of Food and Drug Safety Notice. Regulation on designation of orphan drugs. 2018. Available from: https://www.mfds.go.kr/
eng/brd/m_18/view.do?seq=71453 [Last accessed on 28 Feb 2024].
36. Kang D, Choi SE. Horizontal healthcare utilization inequity in patients with rare diseases in Korea. Int J Equity Health 2023;22:93.
DOI PubMed PMC
37. Appendix 13: designation and registration of orphan medicines. Available from: https://www.npra.gov.my/easyarticles/images/users/
1153/drgd_appendices/APPENDIX-13-Designation-and-Registration-of-Orphan-Medicines.pdf [Last accessed on 28 Feb 2024].
38. Shafie AA, Supian A, Ahmad Hassali MA, et al. Rare disease in Malaysia: challenges and solutions. PLoS One 2020;15:e0230850.
DOI PubMed PMC
39. Parajuli N, Baskota R, Jain R. Genodermatoses picture: difficulties faced and way forward in Nepal. J Nepal Health Res Counc
2023;20:1008-12. PubMed
40. Pandey AS. Case reports of metabolic disorders from Nepal. Mol Genet Metab Rep 2019;21:100542. DOI PubMed PMC
41. Australian Government Department of Health and Aged Care. National strategic action plan for rare diseases. 2020. Available from:
https://www.health.gov.au/resources/publications/national-strategic-action-plan-for-rare-diseases?language=en [Last accessed on 28
Feb 2024].
42. Rare Voices Australia. Implementing the national strategic action plan for rare diseases. May 2023 status report. 2023. Available from:
https://rarevoices.org.au/wp-content/uploads/2023/05/Implementing-the-National-Strategic-Action-Plan-for-Rare-Diseases_May-2023-
Status-Report.pdf [Last accessed on 28 Feb 2024].
43. Department of Health and Aged Care. Pharmaceutical benefits scheme (PBS).
44. Australian Government Department of Health and Aged Care. About the life saving drugs program. 2023. Available from: https://
www.health.gov.au/our-work/life-saving-drugs-program/about-the-lsdp [Last accessed on 28 Feb 2024].
45. Government response. The new frontier: inquiry into approval processes for new drugs and novel medical technologies in Australia.